Cardiovascular Toxicity of Androgen Deprivation Therapy

被引：0
|
作者：
Julia Boland
William Choi
Maximillian Lee
Jianqing Lin
机构：
[1] George Washington University Hospital,Division of Hematology/Oncology and Department of Medicine
[2] George Washington University School of Medicine and Health Sciences,undefined
来源：
Current Cardiology Reports | 2021年 / 23卷
关键词：
Prostate cancer; Androgen deprivation therapy; GnRH antagonist; Coronary artery disease; Cardiovascular toxicity; Cardio-oncology;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Androgen deprivation therapy and cardiovascular disease: what is the linking mechanism?
    Zareba, Piotr
    Duivenvoorden, Wilhelmina
    Leong, Darryl P.
    Pinthus, Jehonathan H.
    THERAPEUTIC ADVANCES IN UROLOGY, 2016, 8 (02) : 118 - 129
  • [32] Cardiovascular risk during androgen deprivation therapy for prostate cancer
    Jones, Thomas Hugh
    BRITISH MEDICAL JOURNAL, 2011, 342
  • [33] Effect of Androgen Deprivation Therapy on Metabolic Complications and Cardiovascular Risk
    Melloni, Chiara
    Nelson, Adam
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2020, 13 (03) : 451 - 462
  • [34] Cardiovascular mortality and androgen deprivation
    Shehzad Basaria
    Nature Reviews Urology, 2009, 6 : 252 - 253
  • [35] The toxicity side-effects of androgen deprivation therapy: the metabolic syndrome
    Chowdhury, Subhra
    Dumas, Lucy
    Chowdhury, Simon
    TRENDS IN UROLOGY & MENS HEALTH, 2014, 5 (02) : 26 - 27
  • [36] Androgen deprivation therapy and cardiovascular morbidity in prostate cancer: a narrative review
    Klemm, Jakob
    von Deimling, Markus
    Fisch, Margit
    Kramer, Gero
    Tilki, Derya
    Steuber, Thomas
    von Amsberg, Gunhild
    Hengstenberg, Christian
    Shariat, Shahrokh F.
    UROLOGIE, 2024, 63 (03): : 262 - 268
  • [37] Effect of androgen deprivation therapy on cardiovascular risk factors in prostate cancer
    Roayaei, Mahnaz
    Ghasemi, Sedighe
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2013, 18 (07): : 579 - 581
  • [38] Perspectives on the Cardiovascular and Metabolic Effects of Androgen Deprivation Therapy in Prostate Cancer
    Daniel Sentana-Lledo
    Alicia K. Morgans
    Current Oncology Reports, 2024, 26 : 299 - 306
  • [39] Risk of Metabolic Syndrome, Cardiovascular Disease, and Diabetes in Androgen Deprivation Therapy
    Leahy, Yvonne
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2008, 12 (05) : 771 - 776
  • [40] Understanding and managing the cardiovascular risks of androgen deprivation therapy for prostate cancer
    Atalar, Kerem
    Rajan, Prabhakar
    NATURE REVIEWS UROLOGY, 2023, 20 (01) : 3 - 4
12345